BioCentury | Sep 12, 2020
Politics, Policy & Law

NIH taking action on racial disparities in Alzheimer’s research

...African Americans and other underserved groups. The University of Alabama at Birmingham...
...communities into clinical development. Danielle Golovin NIH University of New Mexico University of Alabama at Birmingham Vanderbilt...
BioCentury | Jul 15, 2020
Product Development

University of Queensland COVID-19 vaccine becomes seventh with CEPI funding to enter the clinic

...neutralizing antibody titers of 320 by day 28, and that a separate study conducted by University of Alabama at Birmingham...
...BNT162) AdCOVID Coalition for Epidemic Preparedness Innovations (CEPI) Pfizer Inc. BioNTech SE University of Queensland Tonix Pharmaceuticals Holding Corp. Kansas State University Altimmune Inc. University of Alabama at Birmingham SARS-CoV-2...
BioCentury | Jun 26, 2020
Distillery Therapeutics

Promoting Golgi fragmentation to treat pancreatic cancer

...Mass. email: Michael.Green@umassmed.edu CONTACT: Narendra Wajapeyee, University of Alabama at Birmingham, Birmingham, Ala. email: nwajapey@uab.edu Claire Quang University of Massachusetts Medical School University of Alabama at Birmingham...
BioCentury | Mar 31, 2020
Product Development

COVID roundup: Vaccine R&D from Murdoch Children’s, Cobra-Karolinska, Altimmune-Alabama

...€47.5 million in funding across 17 projects. Also Monday, Altimmune Inc. (NASDAQ:ALT) partnered with the University of Alabama at Birmingham...
...Further analysis of the coronavirus crisis can be found at https://www.biocentury.com/coronavirus . Elizabeth S. Eaton, Staff Writer University of Alabama at Birmingham Altimmune...
BioCentury | Nov 1, 2019
Product Development

Vertex’s triple therapy will reshape the landscape of cystic fibrosis trials

...in 2016. Rowe is professor and director of the Cystic Fibrosis Research Center at the University of Alabama at Birmingham...
BioCentury | Jun 1, 2019
Product Development

ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts

...involved in detoxification of anthracyclines; GSTM1 null genotype was associated with an increase in ACD University of Alabama at Birmingham...
BioCentury | Apr 10, 2019
Tools & Techniques

Microbiome makes its mark outside the gut

...Head and neck cancer Enterococcus faecalis increased proliferation of oral squamous cell carcinoma cell lines. University of Alabama at Birmingham...
BioCentury | Mar 29, 2019
Targets & Mechanisms

Next-wave targets at AACR 2019 start filling the blanks in the tumor microenvironment

...than normal bladder samples, and higher MTHFD1P1 expression is associated with poorer prognosis among patients. University of Alabama at Birmingham...
BioCentury | Mar 29, 2019
Targets & Mechanisms

AACR moves in a myeloid direction

...studies implicate pathogenic bacteria from the oral microbiome in cancer progression, including one from the University of Alabama at Birmingham...
...Basel, Switzerland Second Genome Inc., South San Francisco, Calif. Tempest Therapeutics Inc., San Francisco, Calif. University of Alabama at Birmingham...
BioCentury | Dec 8, 2018
Product Development

Intermittent move beyond Blincyto

...strength of the evidence. Mehta is an assistant professor in the lymphoma program at the University of Alabama at Birmingham...
...NYSE:PFE), New York, N.Y. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland University of Alabama at Birmingham...
Items per page:
1 - 10 of 104
BioCentury | Sep 12, 2020
Politics, Policy & Law

NIH taking action on racial disparities in Alzheimer’s research

...African Americans and other underserved groups. The University of Alabama at Birmingham...
...communities into clinical development. Danielle Golovin NIH University of New Mexico University of Alabama at Birmingham Vanderbilt...
BioCentury | Jul 15, 2020
Product Development

University of Queensland COVID-19 vaccine becomes seventh with CEPI funding to enter the clinic

...neutralizing antibody titers of 320 by day 28, and that a separate study conducted by University of Alabama at Birmingham...
...BNT162) AdCOVID Coalition for Epidemic Preparedness Innovations (CEPI) Pfizer Inc. BioNTech SE University of Queensland Tonix Pharmaceuticals Holding Corp. Kansas State University Altimmune Inc. University of Alabama at Birmingham SARS-CoV-2...
BioCentury | Jun 26, 2020
Distillery Therapeutics

Promoting Golgi fragmentation to treat pancreatic cancer

...Mass. email: Michael.Green@umassmed.edu CONTACT: Narendra Wajapeyee, University of Alabama at Birmingham, Birmingham, Ala. email: nwajapey@uab.edu Claire Quang University of Massachusetts Medical School University of Alabama at Birmingham...
BioCentury | Mar 31, 2020
Product Development

COVID roundup: Vaccine R&D from Murdoch Children’s, Cobra-Karolinska, Altimmune-Alabama

...€47.5 million in funding across 17 projects. Also Monday, Altimmune Inc. (NASDAQ:ALT) partnered with the University of Alabama at Birmingham...
...Further analysis of the coronavirus crisis can be found at https://www.biocentury.com/coronavirus . Elizabeth S. Eaton, Staff Writer University of Alabama at Birmingham Altimmune...
BioCentury | Nov 1, 2019
Product Development

Vertex’s triple therapy will reshape the landscape of cystic fibrosis trials

...in 2016. Rowe is professor and director of the Cystic Fibrosis Research Center at the University of Alabama at Birmingham...
BioCentury | Jun 1, 2019
Product Development

ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts

...involved in detoxification of anthracyclines; GSTM1 null genotype was associated with an increase in ACD University of Alabama at Birmingham...
BioCentury | Apr 10, 2019
Tools & Techniques

Microbiome makes its mark outside the gut

...Head and neck cancer Enterococcus faecalis increased proliferation of oral squamous cell carcinoma cell lines. University of Alabama at Birmingham...
BioCentury | Mar 29, 2019
Targets & Mechanisms

Next-wave targets at AACR 2019 start filling the blanks in the tumor microenvironment

...than normal bladder samples, and higher MTHFD1P1 expression is associated with poorer prognosis among patients. University of Alabama at Birmingham...
BioCentury | Mar 29, 2019
Targets & Mechanisms

AACR moves in a myeloid direction

...studies implicate pathogenic bacteria from the oral microbiome in cancer progression, including one from the University of Alabama at Birmingham...
...Basel, Switzerland Second Genome Inc., South San Francisco, Calif. Tempest Therapeutics Inc., San Francisco, Calif. University of Alabama at Birmingham...
BioCentury | Dec 8, 2018
Product Development

Intermittent move beyond Blincyto

...strength of the evidence. Mehta is an assistant professor in the lymphoma program at the University of Alabama at Birmingham...
...NYSE:PFE), New York, N.Y. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland University of Alabama at Birmingham...
Items per page:
1 - 10 of 104